stockrow
Saturday 31 October 2026
Export DOC’s income statement to Excel — free account
Healthpeak Properties, Inc.
DOC Real Estate Reit Healthcare Facilities
Healthpeak Properties, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.8 billion, up 4.52% from fiscal 2024. In the quarter to June 2026, revenue grew 11.1%, EPS grew 60.0%, free cash flow fell 30.5% and total debt rose 11.0%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for five consecutive years, operating cash flow growth for five.
19.03
0.09
+0.48%
Follow DOC
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
160.80 | 57.91 | 35.77 | 27.35 | 38.81 | 38.27 | 344.70 | 12.52 | 29.78 | 22.22 |
Piotroski F-Score |
4 | 6 | 5 | 5 | 8 | 6 | 5 | 5 | 4 | 6 |
P/S ratio |
3.97 | 5.07 | 5.02 | 6.65 | 10.26 | 9.89 | 9.60 | 7.15 | 6.57 | 6.53 |
P/FCF ratio |
32.98 | 12.29 | 31.23 | 0.00 | 17.67 | 161.80 | 0.00 | 6.73 | 9.90 | 14.29 |
P/Operating CF |
38.06 | 48.31 | 47.38 | 66.23 | 86.86 | 74.42 | 78.79 | 61.22 | 58.07 | 64.56 |
P/B ratio |
1.37 | 1.51 | 1.59 | 1.91 | 2.76 | 2.23 | 2.57 | 2.03 | 2.17 | 2.34 |
Price to Tangible BV |
1.51 | 1.68 | 1.67 | 2.03 | 2.97 | 2.40 | 2.67 | 2.13 | 2.34 | 2.55 |
EV/Sales |
7.26 | 8.23 | 8.10 | 9.74 | 13.40 | 13.66 | 12.91 | 10.09 | 10.79 | 10.79 |
EV/EBITDA |
13.90 | 17.34 | 16.43 | 20.84 | 27.79 | 28.82 | 24.62 | 18.49 | 21.04 | 17.33 |
EV/Operating CF |
16.38 | 20.76 | 18.47 | 22.30 | 31.95 | 29.62 | 27.24 | 21.96 | 23.55 | 18.92 |
EV/FCF |
60.42 | 19.94 | 50.35 | (219.14) | 23.08 | 223.30 | (19.96) | 9.49 | 16.25 | 23.59 |
Quick Ratio |
0.86 | 0.36 | 0.34 | 0.23 | 0.34 | 0.20 | 0.30 | 0.48 | 0.31 | 0.44 |
Current Ratio |
2.82 | 2.56 | 0.67 | 0.72 | 0.90 | 0.46 | 0.72 | 0.64 | 1.09 | 2.37 |
Net Debt/EBITDA |
6.32 | 6.66 | 6.24 | 6.61 | 6.52 | 7.94 | 6.05 | 6.18 | 8.23 | 6.83 |
Debt/Assets |
48.48% | 43.72% | 43.80% | 41.20% | 40.44% | 39.56% | 42.77% | 43.78% | 55.94% | 58.31% |
Debt/Equity |
1.21 | 0.96 | 1.00 | 0.90 | 0.87 | 0.86 | 0.90 | 0.85 | 1.41 | 1.55 |
Asset Turnover |
0.14 | 0.15 | 0.14 | 0.13 | 0.12 | 0.11 | 0.09 | 0.09 | 0.12 | 0.11 |
Operating CF/Net income |
17.76 | 4.42 | 3.14 | 1.81 | 1.58 | 1.84 | 19.23 | 0.80 | 2.05 | 1.94 |
Capex/Depreciation |
(0.96) | 0.05 | (0.93) | (1.60) | 0.51 | (1.05) | (2.90) | 1.93 | 0.67 | (0.39) |
Interest Coverage |
1.70 | 1.13 | 2.11 | 1.99 | 2.00 | 0.70 | 1.32 | 1.15 | 1.25 | 1.53 |
| 0.82% | 3.04% | 4.33% | 6.99% | 7.00% | 5.89% | 0.67% | 17.48% | 7.16% | 7.99% | |
| 0.35% | 1.36% | 1.93% | 3.21% | 3.22% | 2.75% | 0.33% | 7.90% | 2.77% | 3.37% | |
ROIC |
1.86% | 1.12% | 1.94% | 1.59% | 1.51% | 0.71% | 1.43% | 1.57% | 1.79% | 2.96% |
Return on Tangible Assets |
0.41% | 1.43% | 2.37% | 3.89% | 3.99% | 3.84% | 0.54% | 10.51% | 3.84% | 5.27% |
Average Days of Receivables |
10.13 | 10.38 | 9.34 | 9.46 | 9.37 | 9.38 | 13.20 | 14.76 | 8.04 | 7.73 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
3.20% | 3.60% | 4.36% | 6.36% | 5.18% | 5.67% | 7.50% | 8.12% | 4.80% | 4.87% |
Intangible Assets out of Total Assets |
0.04 | 0.04 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 |
Share Based Compensation of Revenue |
0.51% | 0.58% | 0.66% | 1.28% | 0.96% | 1.06% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(0.98) | (0.66) | (0.76) | (0.59) | (0.39) | (0.51) | (0.41) | (0.45) | (0.66) | (0.63) |
Graham Number |
5.13 | 10.27 | 12.59 | 16.70 | 16.56 | 15.51 | 5.49 | 26.28 | 15.29 | 19.58 |
Earnings Yield |
0.62% | 1.73% | 2.80% | 3.66% | 2.58% | 2.61% | 0.29% | 7.98% | 3.36% | 4.50% |
Free Cash Flow Yield |
3.03% | 8.14% | 3.20% | (0.67%) | 5.66% | 0.62% | (6.74%) | 14.86% | 10.10% | 7.00% |
Revenue per Share |
4.06 | 4.00 | 3.99 | 3.83 | 3.52 | 3.10 | 2.55 | 2.53 | 3.94 | 4.56 |
Operating CF per Share |
1.80 | 1.58 | 1.75 | 1.67 | 1.48 | 1.43 | 1.74 | 1.80 | 1.81 | 2.60 |
Capex per Share |
(1.31) | 0.07 | (1.11) | (1.84) | 0.57 | (1.24) | (4.11) | 2.37 | 0.81 | (0.52) |
Free Cash Flow per Share |
0.49 | 1.65 | 0.64 | (0.17) | 2.04 | 0.19 | (2.37) | 4.17 | 2.62 | 2.08 |
Cash per Share |
0.77 | 0.27 | 0.31 | 0.24 | 0.39 | 0.21 | 0.19 | 0.30 | 0.18 | 0.29 |
Shareholders Equity per Share |
11.70 | 13.40 | 12.57 | 13.33 | 13.10 | 13.74 | 13.71 | 13.84 | 11.94 | 12.72 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
11.70 | 13.40 | 12.57 | 13.33 | 13.10 | 13.74 | 13.71 | 13.84 | 11.94 | 12.72 |
Free Cash Flow |
339.32 | 1,114.76 | 350.84 | (91.62) | 1,100.79 | 100.59 | (1,154.66) | 1,963.46 | 1,227.13 | 973.40 |
Working Capital |
1,306.14 | 1,128.50 | (213.90) | (217.38) | (79.14) | (411.54) | (128.33) | (140.57) | 34.52 | 572.70 |
Capital Expenditures |
(912.63) | 44.27 | (605.40) | (991.88) | 305.54 | (657.84) | (2,000.73) | 1,114.75 | 380.09 | (240.73) |
Net Current Asset Value |
(10,168.50) | (9,029.39) | (8,379.51) | (8,033.53) | (7,522.52) | (8,281.06) | (7,036.21) | (5,954.95) | (8,057.26) | (8,827.90) |
EV/EBIT |
39.47 | 70.44 | 41.86 | 58.24 | 80.58 | 145.95 | 93.36 | 43.41 | 51.90 | 32.38 |
Capex to Sales |
0.32 | (0.02) | 0.28 | 0.48 | (0.16) | 0.40 | 1.61 | (0.94) | (0.21) | 0.11 |
Price to Operating Income |
21.54 | 43.40 | 25.96 | 39.76 | 61.68 | 105.75 | 69.42 | 30.76 | 31.61 | 19.61 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.06 | 0.06 | 0.05 | 0.05 | 0.05 | 0.06 | 0.08 | 0.06 | 0.05 | 0.05 |
Cash ROIC |
1.83% | 6.21% | 2.52% | (0.66%) | 8.19% | 0.73% | (9.05%) | 16.07% | 9.05% | 6.38% |
Accounts Receivable Turnover |
36.39 | 40.72 | 39.92 | 40.37 | 41.69 | 37.77 | 26.67 | 26.80 | 43.06 | 45.28 |
Accounts Payable Turnover |
1.56 | 1.55 | 1.26 | 1.13 | 1.02 | 1.28 | 0.95 | 0.95 | 1.63 | 1.74 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
232.27 | 246.31 | 265.92 | 326.72 | 356.55 | 354.77 | 412.10 | 377.46 | 220.09 | 206.31 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
77.57 | 66.32 | 54.63 | 51.06 | 45.48 | 43.56 | 46.51 | 44.45 | 42.92 | 47.02 |
Average Payables |
721.93 | 691.27 | 714.84 | 763.93 | 758.00 | 609.07 | 424.56 | 396.66 | 409.55 | 424.07 |
Average Assets |
20,137.14 | 17,818.56 | 15,735.04 | 15,514.38 | 15,588.81 | 14,976.49 | 13,375.72 | 13,403.51 | 14,923.86 | 18,604.56 |
Average Common Equity |
8,598.94 | 7,965.53 | 7,029.32 | 7,120.68 | 7,174.36 | 6,978.71 | 6,590.03 | 6,053.76 | 5,768.12 | 7,843.81 |
Columns are period end dates